ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,401 | 67.01398 | 0 |
female
| 0 | 32 | 1,940 |
Lung Cancer
|
Cancer
| 1 | 10 |
under $11k
| 0 | null | null | null | 6.25 |
white
| 16.398438 | 9 | 0.714966 | 0.434998 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 32 | 96 | 9.298828 | 52 | 20 | 37 | null | null | 0.399963 | 0.799927 | 138 | null | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
3,402 | 80.44098 | 1 |
male
| 1 | 70 | 70 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 221,947.625 | 148,211 | null | 47 |
white
| 31 | 57 | 0.521973 | 0.405945 | 7 | 0 | 0 |
no
| 0.7 | 0.65 |
dnr after sadm
| 69 | 58 | 14.599609 | 154 | 10 | 38.59375 | 135 | 2 | 3.299805 | 1 | 132 | 7.399414 | null | null | null | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
3,403 | 46.45898 | 0 |
male
| 0 | 33 | 1,939 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 |
$25-$50k
| 0 | 87,008.125 | 59,460.2812 | null | 23 |
white
| 34.898438 | 65 | 0.675903 | 0.581909 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 33 | 45 | 25.199219 | 124 | 28 | 39 | 206.65625 | 3.799805 | 2.199707 | 1.399902 | 140 | 7.5 | null | null | null | null | 0 |
SIP>=30
| 0 |
3,404 | 64.04095 | 1 |
female
| 0 | 13 | 75 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
$11-$25k
| 0 | 12,177 | null | null | 13.5 |
white
| 29 | 43 | 0.504883 | 0.387939 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.3 |
no dnr
| 13 | 107 | 0.699951 | 100 | 29 | 37.09375 | 371.375 | null | 0.5 | 0.599976 | 132 | 7.469727 | null | null | null | 5 | 5 |
adl>=4 (>=5 if sur)
| 5 |
3,405 | 63.211 | 1 |
male
| 0 | 10 | 1,132 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 8,286.344 | 6,482.3594 | null | 11.5 |
white
| 14.599609 | 15 | 0.911987 | 0.850952 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 10 | 70 | 8 | 80 | 20 | 36.39844 | 428.5625 | null | 1.5 | 1.099854 | 142 | 7.459961 | null | null | null | null | null | null | 2.336914 |
3,406 | 44.909 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 45,405.188 | 28,532.3281 | null | 50 |
black
| 32.898438 | 57 | 0.709961 | 0.621948 | 3 | 1 | 0 |
no
| 0.25 | 0.25 |
no dnr
| 5 | 112 | 21.796875 | 146 | 55 | 39 | 94 | 2.099609 | 0.199982 | 0.799927 | 142 | 7.349609 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,407 | 38.784 | 1 |
male
| 0 | 6 | 38 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 8,524.148 | 5,521.2148 | null | 12 |
white
| 22.199219 | 10 | 0.66394 | 0.362976 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 6 | 103 | 23.097656 | 90 | 20 | 36.5 | null | 3 | 0.299988 | 0.899902 | 139 | null | null | null | null | null | null |
<2 mo. follow-up
| 2.14209 |
3,408 | 45.00497 | 1 |
male
| 0 | 97 | 142 |
Coma
|
Coma
| 0 | 12 |
$25-$50k
| 100 | 177,418.375 | 120,515.938 | null | 32.75 |
white
| 21.898438 | 32 | 0.387939 | 0.313965 | 6 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 4 | 130 | 19.597656 | 130 | 10 | 38.69531 | 246.65625 | null | null | 1 | 140 | 7.539062 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
3,409 | 65.91595 | 1 |
male
| 0 | 8 | 41 |
Lung Cancer
|
Cancer
| 1 | 1 |
under $11k
| 0 | null | null | null | 6.5 |
black
| 16 | 15 | 0.724976 | 0.450989 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 8 | 73 | 6.199219 | 90 | 18 | 36.5 | null | null | null | 0.799927 | 135 | null | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
3,410 | 49.89697 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 37 | 36,192.281 | 24,370.8906 | null | 44.5 |
white
| 28 | 46 | 0.631958 | 0.529907 | 5 | 0 | 0 |
no
| 0.4 | 0.4 |
no dnr
| 7 | 73 | 0.299988 | 116 | 33 | 37.79688 | 225 | null | 0.399963 | 1.199951 | 135 | 7.40918 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,411 | 55.28799 | 1 |
female
| 1 | 25 | 25 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 7 |
$11-$25k
| 9 | null | null | null | 21.25 |
white
| 23.898438 | 31 | 0.727905 | 0.574951 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 25 | 84 | 6.099609 | 110 | 24 | 36.89844 | null | 3.199707 | 6.699219 | 1.399902 | 140 | 7.469727 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
3,412 | 33.254 | 1 |
male
| 1 | 61 | 61 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
under $11k
| 9 | 123,138.188 | 84,588.25 | null | 21.25 |
black
| 43.695313 | 96 | 0.085999 | 0.032997 | 31 | 0 | 0 |
yes
| 0.2 | 0.2 |
dnr after sadm
| 61 | 69 | 0.399963 | 145 | 52 | 39.39844 | 373.3125 | 2 | 16.296875 | 1.699951 | 148 | 7.509766 | null | null | null | 0 | 0 | null | 0 |
3,413 | 45.97098 | 0 |
male
| 0 | 16 | 1,934 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$11-$25k
| 0 | 34,001.469 | 24,492.7812 | null | 27 |
white
| 31.597656 | 21 | 0.778931 | 0.645996 | 1 | 1 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 16 | 80 | 14.398438 | 114 | 26 | 36.79688 | 283.3125 | 2.799805 | 1.399902 | 1 | 125 | 7.369141 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,414 | 79.81897 | 1 |
male
| 1 | 17 | 17 |
MOSF w/Malig
|
ARF/MOSF
| 2 | null | null | 44 | 89,738.938 | 61,880.625 | null | 41 |
white
| 36.796875 | 73 | 0.051994 | 0.016998 | 24 | 0 | 0 |
yes
| 0.2 | 0.1 |
dnr after sadm
| 7 | 63 | 0.399963 | 112 | 10 | 37.19531 | 131.65625 | null | 0.599976 | 9.199219 | 134 | 7.469727 | null | null | null | null | null |
<2 mo. follow-up
| 3.064453 |
3,415 | 75.30194 | 1 |
male
| 1 | 3 | 3 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 61 | 23,312.641 | 15,998.5312 | null | 39 | null | 78.09375 | 81 | 0 | 0 | 7 | 0 | 0 |
yes
| 0.4 | 0.4 |
dnr after sadm
| 3 | 0 | 58.59375 | 0 | 0 | 39.59375 | 137.75 | 2.5 | 0.899902 | 1.699951 | 149 | 7.439453 | null | null | null | null | null |
<2 mo. follow-up
| 1.544189 |
3,416 | 60.30399 | 1 |
male
| 0 | 9 | 40 |
Colon Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | null | null | null | 18 |
black
| 22.097656 | 18 | 0.747925 | 0.487 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
no dnr
| 9 | 93 | 4.899414 | 112 | 28 | 39.79688 | null | null | 0.699951 | 0.699951 | 133 | null | null | null | null | 2 | 0 |
<2 mo. follow-up
| 0 |
3,417 | 59.62198 | 0 |
male
| 0 | 5 | 1,933 |
CHF
|
COPD/CHF/Cirrhosis
| 0 | null | null | 0 | 14,459.148 | 9,915.3906 | null | 21 |
white
| 20.097656 | 19 | 0.875977 | 0.792969 | 1 | 0 | 0 |
no
| 0.95 | 0.85 |
no dnr
| 5 | 97 | 10.298828 | 110 | 24 | 36.39844 | 210 | null | null | 1 | 137 | 7.449219 | null | null | null | null | null | null | 2.17041 |
3,418 | 43.159 | 1 |
male
| 0 | 4 | 701 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | null | null | 0 | 13,811 | null | null | 6 |
black
| 14.699219 | 11 | 0.941895 | 0.900879 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 77 | 4.299805 | 90 | 18 | 36.89844 | null | null | 0.799927 | 0.799927 | 138 | null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.215332 |
3,419 | 68.19196 | 1 |
male
| 1 | 20 | 20 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 9 |
under $11k
| 0 | 69,824.688 | 46,296.5 | null | 28.333328 |
white
| 25.699219 | 29 | 0.707886 | 0.547974 | 11 | 1 | 0 |
no
| 0.4 | 0.4 |
dnr after sadm
| 7 | 83 | 13.398438 | 98 | 8 | 35.89844 | 156 | null | null | 1.299805 | 152 | 7.469727 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,420 | 77.98798 | 1 |
female
| 0 | 23 | 180 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null |
under $11k
| 0 | null | null | null | 26 |
white
| 17.898438 | 18 | 0.824951 | 0.713989 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 23 | 113 | 15.199219 | 82 | 25 | 37.59375 | 303.3125 | 3.599609 | 0.299988 | 0.399963 | 137 | 7.419922 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,421 | 68.99396 | 1 |
female
| 0 | 23 | 1,659 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 9 | 53,060.125 | 36,860.4375 | null | 26.333328 |
black
| 19.796875 | 32 | 0.816895 | 0.754883 | 2 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 23 | 118 | 7.199219 | 150 | 20 | 38.59375 | 206.65625 | 2.899902 | null | 0.799927 | 138 | 7.519531 | null | null | null | null | null | null | 1.861084 |
3,422 | 50.40097 | 0 |
male
| 0 | 7 | 1,931 |
Lung Cancer
|
Cancer
| 1 | 14 |
$11-$25k
| 0 | 4,376.5 | 3,473.1387 | null | 5.5 |
other
| 18.199219 | 23 | 0.718994 | 0.441956 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.2 |
no dnr
| 7 | 83 | 2.699707 | 52 | 24 | 37.5 | null | null | 0.699951 | 1.5 | 133 | null | null | null | null | null | 5 | null | 5 |
3,423 | 77.10596 | 1 |
male
| 1 | 11 | 11 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 28,218.141 | 19,108.8438 | null | 28.5 |
white
| 19.597656 | 27 | 0.720947 | 0.634888 | 5 | 0 | 0 |
yes
| 0.75 | 0.5 |
dnr after sadm
| 5 | 103 | 10.798828 | 112 | 9 | 37.59375 | 213.3125 | 2.399902 | 0.399963 | 0.799927 | 143 | 7.449219 | null | null | null | null | null |
<2 mo. follow-up
| 1.948975 |
3,424 | 80.13397 | 1 |
male
| 1 | 17 | 17 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 3 |
$25-$50k
| 0 | 67,287.125 | 45,010.0625 | null | 42.666657 |
white
| 32.296875 | 59 | 0.56897 | 0.45697 | 1 | 1 | 0 |
no
| 0.2 | 0.2 |
dnr after sadm
| 2 | 59 | 10.5 | 94 | 12 | 38 | 85 | null | 1 | 2.399902 | 130 | 7.359375 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,425 | 71.05298 | 1 |
female
| 0 | 71 | 183 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
under $11k
| 0 | 73,721.125 | 52,616.9062 | null | 15.25 |
white
| 16.5 | 17 | 0.873901 | 0.789917 | 1 | 0 | 0 |
no
| 0.99 | 0.9 |
no dnr
| 71 | 103 | 26 | 98 | 18 | 36.09375 | 385.6875 | 4 | 0.599976 | 0.899902 | 142 | 7.489258 | null | null | null | 1 | 1 |
no(M2 and SIP pres)
| 1 |
3,426 | 65.073 | 1 |
male
| 0 | 10 | 1,910 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 9 |
$11-$25k
| 0 | 8,162.348 | 6,030.125 | null | 11.5 |
white
| 19.597656 | 34 | 0.835938 | 0.731934 | 1 | 0 | 0 |
yes
| 0.9 | 0.75 |
no dnr
| 10 | 90 | 20.199219 | 75 | 26 | 35.79688 | 214.28125 | null | 0.699951 | 1 | 137 | 7.399414 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,427 | 39.43597 | 1 |
male
| 1 | 25 | 25 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 0 | 111,050.375 | 72,371.5625 | null | 41.25 |
white
| 24.5 | 55 | 0.850952 | 0.799927 | 4 | 0 | 0 |
no
| null | null |
dnr after sadm
| 21 | 59 | 16.898438 | 115 | 60 | 38.29688 | 226.65625 | null | 0.599976 | 1.099854 | 133 | 7.379883 | null | null | null | null | null |
<2 mo. follow-up
| 1.862793 |
3,428 | 77.02698 | 1 |
male
| 1 | 85 | 85 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 15 |
$25-$50k
| 9 | 86,263 | 63,587.5625 | null | 16.5 |
white
| 23 | 41 | 0.625 | 0.439941 | 9 | 0 | 0 |
yes
| 0.6 | 0.6 |
dnr after sadm
| 6 | 67 | 20.699219 | 135 | 31 | 38.39844 | 211.40625 | null | 0.299988 | 1.5 | 140 | 7.40918 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
3,429 | 37.41498 | 0 |
female
| 0 | 14 | 1,927 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 140,070.375 | 98,097.8125 | null | 15 |
black
| 26.398438 | 36 | 0.79895 | 0.731934 | 46 | 1 | 0 |
no
| 0.98 | 0.98 |
no dnr
| 14 | 111 | 19.097656 | 98 | 16 | 35.5 | 268 | 2.799805 | 0.299988 | 5 | 138 | 7.40918 | null | null | null | null | null | null | 2.78125 |
3,430 | 48.84299 | 0 |
female
| 0 | 21 | 1,927 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 9 |
$25-$50k
| 0 | 55,942.812 | 36,934.5 | null | 26.666656 |
black
| 25.699219 | 30 | 0.814941 | 0.75293 | 3 | 0 | 0 |
no
| 0.92 | 0.9 |
no dnr
| 21 | 77 | 20.296875 | 142 | 10 | 39.09375 | 168 | 2.699707 | null | 0.799927 | 135 | 7.379883 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,431 | 65.04596 | 1 |
female
| 1 | 30 | 30 |
MOSF w/Malig
|
ARF/MOSF
| 0 | null |
under $11k
| 100 | 87,928.938 | 61,871.6562 | null | 28.5 |
black
| 18.296875 | 8 | 0.27594 | 0.167999 | 12 | 0 | 0 |
yes
| 0.1 | 0.001 |
dnr after sadm
| 19 | 93 | 11.398438 | 106 | 11 | 38.5 | 406.625 | 2.599609 | 0.5 | 1 | 133 | 7.459961 | null | null | null | null | 2 |
<2 mo. follow-up
| 2 |
3,432 | 72.29297 | 1 |
male
| 1 | 4 | 4 |
Lung Cancer
|
Cancer
| 5 | null | null | 44 | 1,849.149 | 1,677.3008 | null | 9 |
white
| 23.597656 | 37 | 0.303955 | 0.051994 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 1 | 70 | 5.5 | 64 | 36 | 36.39844 | 335 | null | null | 3.099609 | 142 | 7.369141 | null | null | null | null | null |
<2 mo. follow-up
| 3.919434 |
3,433 | 50.30298 | 1 |
female
| 0 | 7 | 373 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 9 |
$25-$50k
| 0 | null | null | null | 9 |
white
| 21.597656 | 21 | 0.904907 | 0.840942 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
dnr after sadm
| 1 | 108 | 9.5 | 115 | 24 | 35.39844 | 285.6875 | null | 0.299988 | 0.799927 | 142 | 7.339844 | null | null | null | 5 | 5 |
SIP>=30
| 5 |
3,434 | 27.55899 | 0 |
male
| 0 | 24 | 1,922 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
under $11k
| 0 | 54,286.625 | 39,041 | null | 32.666657 |
white
| 23.398438 | 55 | 0.905884 | 0.872925 | 1 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 24 | 70 | 9.5 | 110 | 23 | 36.5 | 280 | 2.099609 | 0.599976 | 7.699219 | 146 | 7.419922 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,435 | 66.31598 | 1 |
male
| 0 | 18 | 397 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 7 |
$11-$25k
| 0 | 27,578.297 | 19,002.8281 | null | 14 |
white
| 19.699219 | 24 | 0.860962 | 0.769897 | 1 | 1 | 0 |
no
| 0.95 | 0.93 |
no dnr
| 18 | 80 | 12.199219 | 100 | 24 | 37.29688 | null | 3.399902 | null | 1.599854 | 136 | null | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
3,436 | 38.74298 | 1 |
female
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 26 | 121,979.062 | 81,317.4375 | null | 51.5 |
white
| 47.09375 | 69 | 0.215973 | 0.118988 | 6 | 0 | 0 |
no
| 0 | 0 |
no dnr
| 7 | 93 | 12.298828 | 112 | 12 | 35.59375 | 144.875 | 4.099609 | 29.199219 | 3.699707 | 142 | 7.399414 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,437 | 82.89697 | 1 |
male
| 1 | 13 | 13 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 3 |
under $11k
| 55 | 37,978.875 | 25,475.9688 | null | 53 |
black
| 38.296875 | 53 | 0.071991 | 0.009998 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 4 | 63 | 18 | 150 | 26 | 37.5 | 135 | 1.599854 | 0.199982 | 1.099854 | 136 | 7.319336 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
3,438 | 60.84299 | 0 |
male
| 0 | 15 | 1,920 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 6 |
$11-$25k
| 9 | 31,849.109 | 23,183.5156 | null | 21.333328 |
white
| 23.5 | 31 | 0.805908 | 0.740967 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 15 | 108 | 20.097656 | 110 | 34 | 38.39844 | 168.5625 | null | 0.599976 | 1 | 146 | 7.429688 | null | null | null | null | null |
no(M2 and SIP pres)
| 1.939941 |
3,439 | 59.48297 | 1 |
male
| 0 | 14 | 137 |
Lung Cancer
|
Cancer
| 2 | 12 |
$25-$50k
| 0 | 10,657.312 | 8,153.3203 | null | 12.666664 |
white
| 18 | 12 | 0.700928 | 0.41394 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 14 | 80 | 11.898438 | 100 | 20 | 38.59375 | 304.75 | null | null | 0.699951 | 135 | 7.5 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,440 | 66.00397 | 1 |
male
| 0 | 6 | 57 |
Colon Cancer
|
Cancer
| 1 | 21 |
>$50k
| 0 | null | null | null | 19 |
white
| 24.296875 | 20 | 0.690918 | 0.40094 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.4 |
no dnr
| 6 | 93 | 6.899414 | 70 | 16 | 36.19531 | null | 2.799805 | 0.399963 | 1.5 | 135 | null | null | null | null | 4 | 4 |
<2 mo. follow-up
| 4 |
3,441 | 55.90698 | 1 |
male
| 0 | 3 | 134 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 2,410.699 | 1,712.7959 | null | 3 |
white
| 17.398438 | 25 | 0.720947 | 0.444946 | 1 | 1 | 0 |
metastatic
| 0.95 | 0.6 |
no dnr
| 3 | 113 | 7.199219 | 80 | 22 | 35.89844 | null | null | null | 1.599854 | 137 | null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.216309 |
3,442 | 83.92596 | 1 |
male
| 0 | 6 | 1,868 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 7 |
under $11k
| 0 | 22,317.844 | 12,897.8828 | null | 25 |
white
| 19.898438 | 31 | 0.751953 | 0.60791 | 1 | 1 | 0 |
yes
| null | null |
no dnr
| 6 | 99 | 11 | 68 | 20 | 36.79688 | 342.8125 | null | null | 2.299805 | 139 | 7.449219 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,443 | 78.11395 | 1 |
male
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 13 |
$11-$25k
| 0 | 67,608.5 | 43,753.75 | null | 44 |
white
| 37.09375 | 57 | 0.273987 | 0.165985 | 7 | 0 | 0 |
yes
| 0 | 0 |
dnr after sadm
| 5 | 43 | 8.898438 | 124 | 25 | 39 | 122.84375 | 2 | null | 1.099854 | 147 | 7.489258 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,444 | 58.09698 | 1 |
male
| 1 | 10 | 10 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 9,295.594 | 6,644.8711 | null | 9.5 |
white
| 29.597656 | 13 | 0.408997 | 0.108994 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
dnr after sadm
| 10 | 90 | 7.899414 | 120 | 24 | 36.79688 | null | 2.599609 | 1.299805 | 0.799927 | 139 | null | null | null | null | null | null |
<2 mo. follow-up
| 3.260742 |
3,445 | 73.04596 | 1 |
female
| 1 | 18 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
$11-$25k
| 0 | 99,060.062 | 63,955.4375 | null | 53.333313 |
black
| 16.5 | 43 | 0.835938 | 0.779907 | 9 | 1 | 1 |
no
| 0.5 | 0.5 |
no dnr
| 18 | 67 | 6.399414 | 68 | 10 | 38.29688 | 533.25 | 1.199951 | 0.299988 | 2.099609 | 141 | 7.419922 | null | null | null | null | 6 |
<2 mo. follow-up
| 6 |
3,446 | 69.15295 | 1 |
female
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 100 | 272,269.5 | 173,140.875 | null | 52.75 |
white
| 28.796875 | 61 | 0.125977 | 0.056 | 32 | 0 | 0 |
no
| null | null |
no dnr
| 28 | 87 | 9.298828 | 100 | 50 | 38.5 | 165 | 4.699219 | 3.099609 | 2 | 140 | 7.5 | null | null | null | null | null |
<2 mo. follow-up
| 4.070313 |
3,447 | 65.52496 | 1 |
female
| 1 | 18 | 18 |
Coma
|
Coma
| 0 | 16 |
$25-$50k
| 100 | 16,579.594 | 12,479.7266 | null | 14 |
black
| 22.597656 | 34 | 0.23999 | 0.173981 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 5 | 62 | 14.599609 | 64 | 28 | 35.29688 | 476.625 | null | 1 | 1.5 | 136 | 7.429688 | null | null | null | null | null |
<2 mo. follow-up
| 2.305664 |
3,448 | 76.77997 | 1 |
male
| 1 | 110 | 110 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 3 |
under $11k
| 0 | 419,652.25 | 280,731 | null | 46.75 |
white
| 26.5 | 54 | 0.633911 | 0.531982 | 15 | 0 | 0 |
no
| null | null |
no dnr
| 110 | 59 | 7 | 142 | 8 | 35.69531 | 226.65625 | 2.799805 | null | 1.899902 | 134 | 7.379883 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
3,449 | 37.74698 | 1 |
female
| 1 | 56 | 56 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 44 | 75,506.125 | 54,050.4688 | null | 22.5 |
black
| 23.597656 | 22 | 0.779907 | 0.707886 | 2 | 0 | 0 |
no
| null | null |
dnr after sadm
| 55 | 63 | 4.299805 | 130 | 10 | 39.29688 | 544 | 2.699707 | 0.099991 | 0.699951 | 135 | 7.389648 | null | null | null | null | null |
<2 mo. follow-up
| 2.404297 |
3,450 | 57.57397 | 1 |
male
| 1 | 5 | 5 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 0 | 13,889.844 | 10,675 | null | 30 |
white
| 27.097656 | 30 | 0.79895 | 0.675903 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
no dnr
| 5 | 74 | 6.199219 | 108 | 14 | 35 | 264 | 2.899902 | 0.699951 | 1.599854 | 135 | 7.469727 | null | null | null | 2 | 0 |
<2 mo. follow-up
| 0 |
3,451 | 53.07898 | 0 |
female
| 0 | 38 | 1,915 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
$11-$25k
| 0 | 59,744.844 | 40,375.875 | null | 19.25 |
white
| 20.097656 | 19 | 0.795898 | 0.728882 | 3 | 0 | 0 |
metastatic
| 0.9 | 0.85 |
no dnr
| 38 | 83 | 9.199219 | 135 | 8 | 37.29688 | 323.3125 | 2.399902 | null | 1 | 132 | 7.40918 | null | null | null | null | 4 |
no(M2 and SIP pres)
| 4 |
3,452 | 62.03998 | 1 |
male
| 0 | 15 | 17 |
Lung Cancer
|
Cancer
| 2 | 9 |
$25-$50k
| 0 | 28,018.188 | 18,572.7344 | null | 21 |
white
| 44.296875 | 43 | 0.046997 | 0.001 | 1 | 0 | 0 |
metastatic
| 0.5 | 0 |
no dnr
| 15 | 112 | 29.597656 | 130 | 36 | 35.79688 | 152.5 | 2.399902 | 0.299988 | 0.599976 | 140 | 7.389648 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,453 | 66.46698 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 | null | 100 | 35,396.781 | 21,861.125 | null | 45 |
black
| 36.296875 | 59 | 0.050995 | 0.015999 | 4 | 1 | 0 |
no
| null | null |
dnr after sadm
| 2 | 45 | 10.599609 | 140 | 36 | 38.59375 | 172.5 | null | null | 1.5 | 143 | 7.319336 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,454 | 55.85498 | 1 |
male
| 1 | 24 | 24 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | null | null | 9 | 19,714.938 | 15,110.1172 | null | 10 |
white
| 39.59375 | 45 | 0.312988 | 0.131989 | 1 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 14 | 90 | 11.199219 | 94 | 18 | 34.39844 | null | 2.799805 | 33 | 1.399902 | 126 | null | null | null | null | null | null |
<2 mo. follow-up
| 3.322754 |
3,455 | 65.81195 | 1 |
male
| 0 | 26 | 51 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 9 | null | 0 | 47,714.625 | 33,123.1562 | null | 25.25 |
white
| 21.296875 | 40 | 0.844971 | 0.744995 | 1 | 1 | 0 |
no
| 0.2 | 0.008 |
no dnr
| 26 | 75 | 8.5 | 110 | 26 | 37.19531 | 312 | null | 0.799927 | 1.699951 | 135 | 7.429688 | null | null | null | 0 | 7 |
<2 mo. follow-up
| 7 |
3,456 | 26.834 | 0 |
female
| 0 | 11 | 1,911 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 16,465.844 | 11,702.9375 | null | 14 |
black
| 34.898438 | 66 | 0.764893 | 0.689941 | 2 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 11 | 136 | 16.898438 | 0 | 0 | 35.89844 | 336 | null | 1.299805 | 5.899414 | 139 | 7.329102 | null | null | null | 0 | 2 | null | 2 |
3,457 | 69.11395 | 1 |
male
| 1 | 15 | 15 |
Coma
|
Coma
| 2 | null |
under $11k
| 100 | 45,662.281 | 31,362.1875 | null | 27 |
black
| 19.398438 | 33 | 0.223999 | 0.16098 | 5 | 1 | 0 |
no
| null | null |
dnr after sadm
| 12 | 123 | 12.099609 | 94 | 35 | 38.09375 | 456.625 | null | null | 1.699951 | 139 | 7.649414 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,458 | 49.71698 | 1 |
male
| 1 | 103 | 103 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
>$50k
| 0 | 345,511.75 | 221,787.375 | null | 50 |
white
| 33.898438 | 47 | 0.699951 | 0.609985 | 1 | 0 | 0 |
no
| 0.05 | 0.000125 |
dnr after sadm
| 18 | 83 | 11.599609 | 140 | 36 | 39 | 73.32812 | 2 | 0.199982 | 0.599976 | 147 | 7.479492 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
3,459 | 43.03897 | 1 |
male
| 0 | 18 | 128 |
Lung Cancer
|
Cancer
| 1 | 14 |
$25-$50k
| 0 | 25,087.047 | 17,921 | null | 12.333328 |
white
| 17.398438 | 22 | 0.75 | 0.48999 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 18 | 100 | 9.599609 | 140 | 18 | 37.29688 | null | 3.599609 | 0.299988 | 1.099854 | 142 | null | null | null | null | 1 | 1 |
adl>=4 (>=5 if sur)
| 1 |
3,460 | 67.85498 | 1 |
male
| 1 | 4 | 4 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 0 | 29,172.891 | 18,237.5938 | null | 45 |
white
| 42.796875 | 57 | 0.314941 | 0.132996 | 3 | 0 | 0 |
no
| null | null |
dnr after sadm
| 4 | 46 | 14.099609 | 62 | 24 | 36.69531 | 160 | null | null | 4 | 124 | 7.419922 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,461 | 76.59698 | 1 |
male
| 1 | 9 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 | null | 0 | 68,324.75 | 45,443.0938 | null | 30.5 |
white
| 17.597656 | 28 | 0.809937 | 0.746948 | 10 | 1 | 0 |
no
| 0.3 | 0.2 |
no dnr
| 9 | 65 | 8 | 58 | 9 | 37.29688 | 242.84375 | null | null | 2 | 142 | 7.439453 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,462 | 54.409 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 41 | 28,525.047 | 19,878.1094 | null | 31 |
white
| 32.398438 | 56 | 0.47699 | 0.358948 | 4 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 103 | 29.097656 | 140 | 24 | 37.59375 | 160 | null | 1.399902 | 2.799805 | 133 | 7.489258 | null | null | null | null | null |
<2 mo. follow-up
| 2.597168 |
3,463 | 71.82996 | 1 |
male
| 0 | 44 | 1,106 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 6 |
under $11k
| 0 | 110,116.562 | 70,567.125 | null | 20.5 |
black
| 19.796875 | 22 | 0.830933 | 0.724976 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 44 | 86 | 15.298828 | 72 | 18 | 37 | null | null | null | 1.799805 | 132 | null | null | null | null | 0 | 1 | null | 1 |
3,464 | 71.91797 | 1 |
male
| 0 | 41 | 1,127 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
under $11k
| 61 | 84,830.938 | 58,373.6875 | null | 26.5 |
white
| 21.5 | 25 | 0.557983 | 0.444946 | 5 | 0 | 0 |
no
| null | null |
dnr after sadm
| 16 | 57 | 5.699219 | 110 | 8 | 38.59375 | 500 | null | null | 0.899902 | 134 | 7.389648 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,465 | 85.57996 | 1 |
male
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 | null | 0 | null | null | null | 37 |
white
| 21.699219 | 42 | 0.751953 | 0.67395 | 2 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 3 | 60 | 23.5 | 62 | 18 | 37.09375 | 149 | 2.299805 | 0.699951 | 1.199951 | 135 | 7.389648 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
3,466 | 61.92697 | 1 |
male
| 0 | 9 | 432 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | null |
under $11k
| 0 | 17,596.484 | 12,805.6875 | null | 22 |
black
| 17.398438 | 30 | 0.899902 | 0.831909 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 9 | 83 | 2 | 80 | 33 | 36.69531 | 216.65625 | null | 0.5 | 1.699951 | 141 | 7.449219 | null | null | null | 1 | 1 | null | 1 |
3,467 | 21.405 | 0 |
female
| 0 | 12 | 1,906 |
CHF
|
COPD/CHF/Cirrhosis
| 0 | 12 |
$11-$25k
| 0 | null | null | null | 5 |
white
| 20.097656 | 14 | 0.944946 | 0.904907 | 1 | 0 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 12 | 65 | 10.898438 | 118 | 20 | 36.5 | null | null | null | 1.099854 | 138 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,468 | 62.83899 | 1 |
female
| 0 | 9 | 167 |
COPD
|
COPD/CHF/Cirrhosis
| 5 | 3 |
under $11k
| 0 | 15,547.047 | 11,720.3203 | null | 13 |
black
| 21.796875 | 36 | 0.855957 | 0.761963 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 9 | 100 | 10.599609 | 92 | 16 | 36.59375 | 252 | 3.299805 | 0.099991 | 7.099609 | 136 | 7.219727 | null | null | null | null | 0 |
SIP>=30
| 0 |
3,469 | 62.004 | 1 |
female
| 0 | 14 | 1,123 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 |
under $11k
| 0 | 18,162.547 | 13,435.8047 | null | 10 |
black
| 16.898438 | 15 | 0.892944 | 0.85498 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 14 | 77 | 14.898438 | 90 | 24 | 36.29688 | 321.6875 | null | 0.299988 | 0.899902 | 140 | 7.359375 | null | null | null | 0 | 5 |
no(M2 and SIP pres)
| 5 |
3,470 | 59.29599 | 1 |
female
| 0 | 5 | 65 |
Colon Cancer
|
Cancer
| 1 | null | null | 0 | null | null | null | 11 |
white
| 15.898438 | 13 | 0.840942 | 0.650879 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 5 | 100 | 7.599609 | 96 | 20 | 36.79688 | null | 3.599609 | 0.699951 | 0.599976 | 137 | null | null | null | null | null | null | null | 1.702393 |
3,471 | 78.84698 | 1 |
male
| 1 | 5 | 5 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 4,319.68 | 3,077.4668 | null | 12 |
black
| 18.898438 | 26 | 0.831909 | 0.724976 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 62 | 4.5 | 78 | 20 | 35.59375 | 338.0625 | null | null | 1.799805 | 141 | 7.479492 | null | null | null | null | null |
<2 mo. follow-up
| 2.180176 |
3,472 | 65.83997 | 1 |
female
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 | null | 61 | 96,527.75 | 61,453.4062 | null | 51.333313 |
white
| 40.195313 | 68 | 0.068985 | 0.024998 | 2 | 0 | 0 |
yes
| 0.2 | 0.18 |
dnr after sadm
| 16 | 48 | 6.799805 | 110 | 29 | 38.5 | 138 | 2.599609 | 5.099609 | 2.699707 | 137 | 7.359375 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,473 | 66.38995 | 1 |
female
| 0 | 8 | 1,091 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 14,528.797 | 10,640.1562 | null | 9.5 |
black
| 16.398438 | 12 | 0.879883 | 0.836914 | 2 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 8 | 99 | 8.798828 | 62 | 15 | 36.89844 | 319 | null | null | 0.599976 | 140 | 7.419922 | null | null | null | null | null | null | 2.377441 |
3,474 | 79.34296 | 0 |
male
| 0 | 14 | 1,895 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 | null | 0 | 33,593.688 | 23,662.5469 | null | 25 |
white
| 25.597656 | 35 | 0.705933 | 0.544922 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 14 | 66 | 6.399414 | 120 | 8 | 35.79688 | 392.5 | null | null | 2.099609 | 134 | 7.419922 | null | null | null | null | 0 | null | 0 |
3,475 | 67.95898 | 1 |
male
| 0 | 5 | 1,186 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 4 |
under $11k
| 0 | 2,900.449 | 2,445.7988 | null | 11 |
black
| 14.5 | 18 | 0.902954 | 0.837891 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 82 | 7.599609 | 80 | 16 | 36.29688 | 290.4375 | null | null | 1.199951 | 139 | 7.5 | null | null | null | 0 | 2 |
no(M2 and SIP pres)
| 2 |
3,476 | 66.20697 | 1 |
female
| 1 | 4 | 4 |
Colon Cancer
|
Cancer
| 1 | 4 |
under $11k
| 0 | 4,139.977 | 3,156.7598 | null | 21 |
black
| 36.09375 | 51 | 0.379944 | 0.090988 | 1 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr after sadm
| 4 | 93 | 35 | 96 | 28 | 35.79688 | null | null | 6.599609 | 2.199707 | 128 | null | null | null | null | null | 3 |
<2 mo. follow-up
| 3 |
3,477 | 63.168 | 0 |
male
| 0 | 19 | 1,895 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | 11 |
under $11k
| 0 | 24,771.141 | 17,050.9844 | null | 16 |
hispanic
| 21.898438 | 21 | 0.815918 | 0.701904 | 1 | 0 | 0 |
yes
| 0.7 | 0.5 |
no dnr
| 19 | 97 | 11.599609 | 106 | 26 | 37.69531 | 240 | 3.199707 | 0.799927 | 0.899902 | 133 | 7.399414 | null | null | null | 3 | 5 |
SIP>=30
| 5 |
3,478 | 71.48798 | 1 |
female
| 0 | 8 | 1,202 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 8 |
$11-$25k
| 0 | 5,364.898 | 4,105.3789 | null | 10 |
white
| 12.898438 | 14 | 0.907959 | 0.845947 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 8 | 83 | 7.099609 | 54 | 16 | 36.59375 | null | 4 | 0.699951 | 1 | 139 | null | null | null | null | 2 | 5 |
SIP>=30
| 5 |
3,479 | 59.58398 | 1 |
female
| 0 | 7 | 493 |
Colon Cancer
|
Cancer
| 1 | null | null | 0 | 6,601.348 | 4,765.2305 | null | 8 |
white
| 13.898438 | 9 | 0.862915 | 0.692993 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 7 | 87 | 8.599609 | 80 | 20 | 37.69531 | null | null | null | 0.699951 | 142 | null | null | null | null | null | null | null | 1.652344 |
3,480 | 68.39197 | 0 |
male
| 0 | 12 | 1,892 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
$11-$25k
| 9 | 38,632.281 | 26,844.7188 | null | 23 |
white
| 17.296875 | 15 | 0.803955 | 0.738892 | 30 | 0 | 0 |
no
| null | null |
no dnr
| 12 | 112 | 12.398438 | 98 | 16 | 37.39844 | 334.75 | null | 1.299805 | 1.099854 | 138 | 7.429688 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,481 | 31.83299 | 0 |
male
| 0 | 11 | 1,892 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 10 |
under $11k
| 0 | 24,312.484 | 18,691.125 | null | 18.5 |
black
| 19.699219 | 32 | 0.916992 | 0.886963 | 2 | 0 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 11 | 75 | 10.5 | 78 | 25 | 38.59375 | 272 | 2.5 | 5.699219 | 0.899902 | 140 | 7.389648 | null | null | null | 1 | 0 |
SIP>=30
| 0 |
3,482 | 50.23398 | 0 |
female
| 0 | 12 | 1,891 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 58,971.531 | 38,017.8438 | null | 48.5 |
white
| 22.796875 | 30 | 0.846924 | 0.793945 | 3 | 0 | 0 |
no
| 0.1 | 0.001 |
no dnr
| 12 | 68 | 9.798828 | 120 | 12 | 39.09375 | 254.28125 | null | null | 1.799805 | 134 | 7.419922 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,483 | 70.29199 | 1 |
male
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 | null | 44 | 73,765.25 | 50,947.5625 | null | 43 |
black
| 24.796875 | 48 | 0.557983 | 0.445984 | 5 | 0 | 0 |
no
| 0.2 | 0.15 |
dnr after sadm
| 22 | 69 | 5.599609 | 114 | 16 | 38.5 | 148 | null | null | 13.798828 | 139 | 7.389648 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,484 | 55.62799 | 1 |
male
| 0 | 23 | 60 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 13 |
$11-$25k
| 0 | 71,645.5 | 47,409.7812 | null | 38.666657 |
white
| 27.398438 | 30 | 0.774902 | 0.701904 | 2 | 0 | 0 |
no
| 0 | 0 |
no dnr
| 23 | 63 | 11.599609 | 110 | 12 | 38.5 | 145 | 2.699707 | null | 1.199951 | 128 | 7.439453 | null | null | null | null | 0 | null | 0 |
3,485 | 52.293 | 0 |
male
| 0 | 8 | 1,887 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 8,464.25 | 6,247.8789 | null | 5 |
black
| 15.898438 | 8 | 0.922974 | 0.868896 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 8 | 90 | 6.599609 | 88 | 20 | 35.79688 | null | 3.599609 | 1.299805 | 1 | 142 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,486 | 54.78998 | 0 |
female
| 0 | 3 | 1,887 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 | null | 0 | 5,985.949 | 4,069.2969 | null | 5 |
black
| 15.898438 | 3 | 0.918945 | 0.861938 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 3 | 90 | 3.799805 | 94 | 20 | 36.29688 | 320 | null | 0.799927 | 1 | 136 | 7.449219 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
3,487 | 60.69498 | 1 |
female
| 0 | 13 | 470 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 5 |
under $11k
| 0 | 32,884.094 | 22,593.8594 | null | 37.5 |
black
| 25.898438 | 34 | 0.61792 | 0.512939 | 8 | 0 | 0 |
metastatic
| 0.7 | 0.5 |
no dnr
| 13 | 91 | 15.199219 | 114 | 8 | 36.39844 | 305.6875 | null | 1.699951 | 2.099609 | 136 | 7.529297 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,488 | 80.52594 | 0 |
female
| 0 | 4 | 1,887 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 6,475.199 | 4,829.2969 | null | 14 |
black
| 27.699219 | 36 | 0.674927 | 0.503906 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 79 | 7.899414 | 76 | 25 | 36.29688 | 85 | null | 0.5 | 1.899902 | 135 | 7.319336 | null | null | null | null | null | null | 2.589356 |
3,489 | 71.15094 | 1 |
male
| 1 | 49 | 49 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 | null | 26 | 137,788.75 | 93,939.75 | null | 39.25 |
black
| 19.296875 | 39 | 0.786987 | 0.717896 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
dnr after sadm
| 42 | 93 | 7.199219 | 78 | 8 | 35.69531 | 265.6875 | 2.799805 | 0.299988 | 9.699219 | 146 | 7.419922 | null | null | null | null | null |
<2 mo. follow-up
| 2.165527 |
3,490 | 39.84097 | 1 |
male
| 1 | 8 | 8 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5 | 10 |
$11-$25k
| 0 | 31,942.234 | 21,611.3281 | null | 46.5 |
black
| 25.699219 | 42 | 0.814941 | 0.700928 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 8 | 92 | 4.299805 | 110 | 14 | 36.69531 | 207.5 | 1.799805 | 4.799805 | 1.799805 | 134 | 7.399414 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
3,491 | 51.61099 | 1 |
female
| 1 | 44 | 44 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 0 | 136,609.375 | 93,343.875 | null | 42.5 |
white
| 31.898438 | 48 | 0.72998 | 0.645996 | 1 | 0 | 0 |
no
| 0.4 | 0.2 |
dnr after sadm
| 30 | 86 | 22.898438 | 112 | 30 | 36.59375 | 160 | null | 1.299805 | 6.099609 | 141 | 7.299805 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
3,492 | 63.431 | 0 |
female
| 0 | 60 | 1,883 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 150,283.625 | 100,000.75 | null | 36.75 |
white
| 32 | 54 | 0.670898 | 0.574951 | 1 | 0 | 0 |
no
| 0.95 | 0.92 |
no dnr
| 60 | 67 | 13.5 | 188 | 25 | 39.09375 | 76 | null | 0.799927 | 1.299805 | 143 | 7.449219 | null | null | null | null | null | null | 2.333008 |
3,493 | 68.64899 | 1 |
female
| 0 | 13 | 82 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 8 |
under $11k
| 0 | 21,254.391 | 15,073.5391 | null | 28 |
white
| 25.097656 | 39 | 0.748901 | 0.603882 | 4 | 1 | 0 |
no
| 0.6 | 0.45 |
no dnr
| 13 | 70 | 8.699219 | 110 | 10 | 35.5 | 430 | null | null | 1.299805 | 131 | 7.5 | null | null | null | null | 5 |
adl>=4 (>=5 if sur)
| 5 |
3,494 | 38.18198 | 1 |
female
| 0 | 5 | 100 |
Colon Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 3,886.5 | 2,888.7129 | null | 12 |
white
| 20.699219 | 12 | 0.816895 | 0.605957 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 91 | 9.599609 | 126 | 16 | 38.59375 | null | null | 0.699951 | 0.5 | 137 | null | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
3,495 | 73.41296 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 44 | 57,947.938 | 39,225.5938 | null | 50 |
black
| 43.898438 | 73 | 0.059998 | 0.019997 | 4 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 8 | 111 | 9.5 | 102 | 13 | 35.79688 | 153.3125 | 2.699707 | 12.599609 | 4.199219 | 126 | 7.40918 | null | null | null | null | null |
<2 mo. follow-up
| 2.482422 |
3,496 | 56.45999 | 0 |
male
| 0 | 117 | 1,882 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 44 | 253,438.625 | 175,935.75 | null | 34 |
white
| 27.398438 | 59 | 0.559937 | 0.44696 | 8 | 0 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 117 | 67 | 16.097656 | 110 | 36 | 38.59375 | 230 | 2.599609 | 2.599609 | 8.5 | 134 | 7.319336 | null | null | null | null | null | null | 2.549316 |
3,497 | 62.75998 | 1 |
female
| 0 | 8 | 127 |
Colon Cancer
|
Cancer
| 1 | 16 | null | 0 | 6,991.598 | 4,942.6133 | null | 8 |
white
| 17.898438 | 11 | 0.80896 | 0.591919 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 8 | 90 | 11.599609 | 78 | 18 | 35.59375 | null | null | 0.899902 | 0.799927 | 140 | null | null | null | null | 0 | 0 | null | 0 |
3,498 | 71.62195 | 1 |
male
| 0 | 24 | 78 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 10,631.492 | 9,751.5312 | null | 2.333332 |
black
| 22.597656 | 33 | 0.807983 | 0.689941 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 110 | 3.799805 | 76 | 20 | 35.5 | null | null | 0.799927 | 3.399902 | 139 | null | null | null | null | null | null | null | 2.90918 |
3,499 | 83.61096 | 1 |
male
| 0 | 8 | 1,230 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | null | null | 0 | 4,798.297 | 4,055.584 | null | 8 |
black
| 23.296875 | 42 | 0.745972 | 0.599976 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 8 | 67 | 7.5 | 64 | 28 | 37.29688 | null | null | 1.099854 | 2.899902 | 132 | null | null | null | null | null | null | null | 3.824219 |
3,500 | 83.32397 | 1 |
male
| 0 | 10 | 480 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 23 |
$11-$25k
| 0 | 22,936.141 | 16,438.5312 | null | 21 |
white
| 29.097656 | 31 | 0.497986 | 0.379944 | 4 | 0 | 1 |
yes
| null | null |
dnr after sadm
| 3 | 90 | 15.5 | 118 | 24 | 35.59375 | 282.5625 | 2.5 | 3.599609 | 0.699951 | 131 | 7.449219 | null | null | null | 2 | 1 |
SIP>=30
| 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.